Shanghai Tianyong Engineering Co., Ltd. (603895.SH) won the bid for the annual capacity of 540,000 units for the whole line transformation project of the Jin Tan H4J15 assembly line.
Tianyong Intelligent (603895.SH) announced that the company recently received a notice from Jiangsu Jiafeng Engineering Consulting Co., Ltd. (referred to as "...
Shanghai Tianyong Engineering (603895.SH) announced that the company recently received a bid notification from Jiangsu Jiafeng Engineering Consulting Co., Ltd. (referred to as the "bidding agency") regarding the bid of Jiangsu Zhongzhiyang Investment Management Co., Ltd. (referred to as the "bidding party") for the 2024 Jintan H4J15 assembly line capacity of 540,000 units per year. The total project involves the whole line renovation (Phase 1, Phase 2). Shanghai Tianyong Engineering Equipment Co., Ltd. has been selected as the winning bidder for the "2024 Jintan H4J15 assembly line capacity of 540,000 units per year whole line renovation project (Phase 1, Phase 2)" with a bid amount of 31 million yuan for Phase 1 and 21 million yuan for Phase 2.
Related Articles
HK Stock Market Move | ASCENTAGE-B(06855) up over 5% again, the company will welcome multiple milestones and catalyst events this year.
HK Stock Market Move | CSTONE PHARMA-B (02616) rises by more than 9%, included in the FTSE China Small Cap Stock Index, rapid progress in the clinical research of three anti-tumor drug candidates.
HK Stock Market Move | IMMUNEONCO-B(01541) surged over 16%, Amonirufu subcutaneous formulation IMM0306S for the treatment of systemic lupus erythematosus was approved for IND.
HK Stock Market Move | ASCENTAGE-B(06855) up over 5% again, the company will welcome multiple milestones and catalyst events this year.
HK Stock Market Move | CSTONE PHARMA-B (02616) rises by more than 9%, included in the FTSE China Small Cap Stock Index, rapid progress in the clinical research of three anti-tumor drug candidates.
HK Stock Market Move | IMMUNEONCO-B(01541) surged over 16%, Amonirufu subcutaneous formulation IMM0306S for the treatment of systemic lupus erythematosus was approved for IND.
RECOMMEND
